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Abstract
Background: Autophagy can result in cellular adaptation, as well as cell survival or cell death. We investigated
how ginsenoside Rg1(G-Rg1) regulates the relationship between autophagy and apoptosis induced by continuous
starvation.
Methods: H9c2 cells under continuous starvation were treated with or without ginsenoside Rg1, and autophagy and
apoptosis related proteins were assessed over a continuous time course by Western blot. Dynamic fluorescence
intensity of green fluorescent protein (GFP)-LC3 was used to assess autophagosome formation by live cell imaging.
Cyan fluorescent protein (CFP) -Beclin1(BECN1) and yellow fluorescent protein (YFP) -Bcl-2 were co-transfected into cells
to observe ginsenoside Rg1 regulation of BECN1/Bcl-2 interaction using Fluorescence Resonance Energy Transfer (FRET).
Immunoprecipitation was also used to assess BECN1/Bcl-2 interaction over a continuous time course.
Results: In H9c2 cells, starvation induced both apoptosis and autophagy. Cell apoptosis was significantly attenuated in
ginsenoside Rg1-treated conditions, while autophagy was promoted. Ginsenoside Rg1 weakened the interaction
between Beclin1 and Bcl-2, inhibiting apoptosis while promoting autophagy. Our results suggest that autophagy
is beneficial to starved cardiac cells over a period of time. Furthermore, we describe the effect of ginsenoside Rg1
on the relationship between autophagy and apoptosis during starvation.
Conclusions: Our findings provide valuable evidence for employing ginsenoside Rg1 as a specific promoter of
autophagy and inhibitor of apoptosis.
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Background
Although the concept of autophagy was established de-
cades ago, the exact role it plays in pathological processes
remains unclear. In cardiomyocytes, autophagy plays a
dual role, demonstrating either protective or harmful ef-
fects under different pathological conditions [1–5]. Some
studies suggest that autophagy protects cells from oxida-
tive stress and apoptosis, a key survival mechanism, and
maintains energy homeostasis and viability in cell starva-
tion models [6–11]. However, other studies suggest that
autophagy can enhance cardiomyocyte damage induced
by high glucose levels [12] and ischemia/reperfusion [13].
It is somewhat surprising that even under the same patho-
logical condition (e.g. starvation), autophagy can exert
both pro-survival and pro-death effects, two seemingly
opposing roles. It has been demonstrated that excessive
autophagy leads to cell death under starvation conditions.
Thus, the extent of autophagy appears to be critical for
determining whether it will play a protective or harmful
role [14]. However, little research has been done to assess
the dynamic process of autophagy during starvation. It is
currently unclear if the level of autophagy changes at dif-
ferent time points during starvation and, if so, how this
might impact cardiomyocyte health. Therefore, pharmaco-
logical effects should be evaluated in a dynamic fashion,
rather than relying on a single time point.
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Ginsenosides are a group of nontoxic, bioactive compo-
nents derived from the rhizome of Panax ginseng, one of
the mostly commonly used Chinese herbs. Growing evi-
dence suggests that ginsenosides possess protective abil-
ities against coronary artery disease, myocardial ischemia,
cardiac hypertrophy, heart failure and arrhythmia [15–20].
Ginsenoside Rg1, one of the main members of the ginse-
noside family, has been shown to promote angiogenesis
[21–24], to exert anti-hypertension effects [25] and to
positively affect myocardial remodeling [26–28]. A recent
study indicated that Rg1 inhibits apoptosis by regulating
autophagy [13], but the exact mechanism remains unclear.
Furthermore, no study to date has assessed the dynamic
regulation of autophagy by Rg1.
Autophagy and apoptosis can occur simultaneously
in response to starvation, and the interplay between
autophagic and apoptotic pathways is emerging as a
crucial process in determining the initiation of pro-
grammed cell death [29, 30]. Beclin 1, a Bcl-2 interacting
protein, has been implicated as an important regulator of
autophagy [31]. Indeed, the suppression of Beclin 1 ex-
pression impairs autophagy and sensitizes the cells to
starvation-induced apoptosis [32]. Beclin 1 interacts with
anti-apoptotic multi-domain proteins of the Bcl-2 family,
in particular Bcl-2 and its homologue Bcl-X(L), by
virtue of its BH3 domain, an amphipathic alpha-helix
that binds to the hydrophobic cleft of Bcl-2/Bcl-X(L)
[33, 34]. It has been shown that the interaction between
Bcl-2 and Beclin1 leads to the inhibition of autophagy
by interfering with the formation and activity of the au-
tophagy promoter complex, Beclin 1/hVps34 [35]. It
has not yet been determined whether ginsenoside Rg1
regulates autophagy through Bcl-2 and Beclin1.
In the present study, we sought to address the dy-
namic regulation of ginsenoside Rg1 on autophagy for
protecting cardiomyocytes from apoptosis under pro-
longed starvation and the related molecular mechan-




Commercial antibodies and chemicals were purchased
from the following sources: anti-LC3 (L7543) and anti-
caspase 3 (C8487) antibodies, rapamycin (Rap;R8781)
and 3-methyladenine (3-MA;M9281) were purchased
from Sigma-Aldrich; anti-Beclin1 (3738s), anti-Bcl-2
(2870s) and anti-GAPDH (5174s) antibodies were pur-
chased from Cell Signaling Technology. Ginsenoside Rg1
(Purity > 95 %, 110703–201027) were chemically standard-
ized products obtained from the National Institutes for
Food and Drug Control, which was validated by finger-
print chromatographic methodologies.
Starvation model in H9c2 cells and drug treatment
The rat ventricular cell line H9c2 was purchased from the
cell bank of the Chinese Academy of Medical Sciences
(Beijing, China). Cells were cultured in Dulbecco’s modi-
fied Eagles medium (DMEM, Hyclone) containing 10 %
fetal bovine serum (GIBCO), 40 U/ml penicillin and 40
U/ml streptomycin in a humidified atmosphere of 95 %
air/5 % CO2 at 37 °C. Cells were grown to 80 % con-
fluency before being exposed to starvation. To create star-
vation conditions, cardiac myocytes were washed three
times with phosphate-buffered saline (PBS) and were in-
cubated in glucose-free, serum-free DMEM (GIBCO,
11966) at 37 °C for 0, 30, 60, 90, 120, 150, 180, 210 or 240
min or until cell death. Cells cultured in nutrient-rich
medium were used as a control. For the active treatment
study, cells were pre-treated with ginsenoside Rg1 (Rg1)
for 12 h in nutrient-rich medium and then were treated
with ginsenoside Rg1 for 0, 30, 60, 90, 120, 150, 180, 210
or 240 min or until cell death in glucose-free, serum-free
DMEM. Rg1 was first dissolved in DMSO and then di-
luted to the final concentration in culture medium (final
DMSO concentration <1 %).
Cell viability assay
Cells were seeded in 96-well plates (2 × 104 cells per well).
After 48 h, cell viability was measured using the 3-(4,5)-
dimethylthiahiazo (−z-y1)-3,5-diphenytetrazoliumromide
(MTT) assay at different time points (30, 60, 90, 120, 150,
180, 210 or 240 min) following glucose-deprivation. MTT
was dissolved and sterilized in PBS at 0.5 mg/ml, and 100
μL of this solution was added to each well. The plate was
incubated at 37 °C for 4 h before the media was removed.
Approximately 200 μL of dimethyl sulfoxide (DMSO) was
added into each well, and the plate was gently rocked for
10 min to dissolve the dark blue MTTcrystals. Cell viability
was expressed as optical density (OD), which was detected
by use of a microplate reader at 490 nm. The experimental
groups included one normal control group (starvation for 0
min), eight starvation model groups (starvation for 30, 60,
90, 120, 150, 180, 210 or 240 min) and twenty-seven ginse-
noside Rg1 treatment groups (treated with 25, 50 or 100
μM ginsenoside Rg1 for each time point).
Live cell imaging system for green fluorescent protein
(GFP)-LC3
Live cell imaging experiments were carried out for one
model group and one drug treatment group. The treat-
ment group was treated with 100 μM ginsenoside Rg1, as
described above. The H9c2 cells were transfected with
GFP-LC3 expression plasmids using an electroporation ap-
paratus (BTX). The electroporation parameters used were
as follows: square-wave, 100 V/cm, 0.5 ms and 5 impulses.
Electroporation was carried out in low conductivity elec-
troporation buffer (10 mM phosphate, 1 mM MgCl2, 250
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mM sucrose, pH 7.4). Cells were allowed to recover for
20 min following electroporation and before being
placed in normal medium and returned to normal cul-
ture conditions. After 48 h, the transfected cells were
glucose deprived for 24 h. The dynamic changes in
color and fluorescence intensity were evaluated in the
same cell selected at different times using the live cell
imaging system (Olympus).
Terminal dexynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) assay
TUNEL experiments were carried out for nine model and
nine treatment groups. The treatment groups were treated
with 100 μM ginsenoside Rg1, as described above. TUNEL
assays (Roche, 1684795) were then performed according to
the protocol provided by the manufacturer. Slides rinsed
with PBS were counterstained with 1 mM of Hoechst stain
(Sigma, 861405). The fluorescein isothiocyanate (FITC)-la-
beled TUNEL-positive cells were imaged using the Syn-
ergy™ 4 Hybrid Microplate Reader system (BioTek) with
488 nm excitation and 530 nm emission wavelengths.
The cells with green fluorescence were classified as
apoptotic cells.
Flow cytometric analysis
Flow cytometry was carried out for nine model and nine
treatment groups (allocated as in the TUNEL assay).
H9c2 cells with or without Rg1 treatments were trypsi-
nized and resuspended in cell culture medium; at least
105 cells were collected. The cells were washed twice
with PBS, then 5 μl FITC-Annexin V and 5 μl propidium
iodide (PI) were added to the cells, and the cells were in-
cubated in the dark at room temperature for 15 min.
Binding buffer was added, and cells were analyzed by
flow cytometry within 30 min.
Immunoprecipitation assay
A time-effect study was carried out for nine model and
nine treatment groups (allocated as in the TUNEL
assay). Whole-cell lysates were used for immunoprecipi-
tation with antibodies against Beclin1. Ten micrograms
of antibody was incubated with 1 ml of cell lysate at 4 °C
overnight. After the addition of Protein A/G-agarose
beads, the incubation was continued for a further 4 h.
After centrifugation, the immunoprecipitates were ex-
tensively washed with lysis buffer 3–4 times and eluted
with loading buffer. Bcl-2 antibodies were used in the
subsequent Western blot experiments.
Western blot analysis
Western blot experiments were carried out for nine model
and nine treatment groups (allocated as in the TUNEL
assay). Protein samples were extracted from H9c2 cells.
Preparation of protein samples consisted of several steps,
including splitting, centrifugation and boiling. Protein
samples (20 μg) were fractionated by sodium salt (SDS)-
Polyacrylamide gel electrophoresis (PAGE) (10 or 12 %
polyacrylamide gels), transferred to a polyvinylidene difluor-
ide (PVDF) membrane and then blocked in 5 % bovine
serum albumin and prepared in a Tris-buffered saline
(TBS) for 1 h at room temperature. The membranes were
incubated with primary antibodies (GAPDH as a loading
control) overnight at 4 °C then washed five times with
0.1 % Tween-20 in Tris-buffered saline (TBS-T) for 30
min each. The membrane was then incubated with
horseradish peroxidase (HRP)-conjugated secondary anti-
bodies for 1 h at room temperature. After washing, the im-
munoreactive protein bands were developed by enhanced
chemiluminescence (ECL), and the resulting membranes
were imaged using the gel imaging system (BIO-RAD).
FRET measurements
FRET experiments were carried out for five groups, in-
cluding one control group, one model group and three
treatment groups (25, 50 and 100 μM ginsenoside Rg1
pretreatment, respectively). Experiments were performed
in H9c2 cells stably co-expressing Cyan fluorescent pro-
tein (CFP) -BECN1 and Yellow fluorescent protein (YFP)
-Bcl-2. The cells were washed with glucose-free Tyrode’s
solution three times and cultured in glucose-free Tyrode’s
solution with or without Rg1 treatment at 37 °C until cell
death. Fluorescence was measured with the microplate
system every 10 min with the excitation wavelength of
CFP and emission wavelength of YFP set at 436 nm and
527 nm, respectively.
Statistical analysis
Quantitative data were expressed as mean ± standard devi-
ation (SD). Differences between experimental groups were
examined by one-way analysis of variance (ANOVA), and
means of two groups were compared using Student’s t-test
(paired, 2-tailed) by SPSS 18.0 software. For all ana-
lyses, p <0.05 was considered statistically significant.
Results
Ginsenoside Rg1 inhibits starvation induced-apoptosis,
contributing to cardioprotection
During starvation, cell survival significantly decreased in a
time-dependent manner between 30 and 240 min when
compared with the 0 min (Additional file 1: Figure S1). At
240 min, 40 % cell death had occurred, so this time
point was deemed an adequate duration for serum and
glucose deprivation in subsequent experiments. To evaluate
whether Rg1 protects H9c2 cardiomyocytes under starva-
tion conditions, cell viability was also measured after pre-
treatment with cultured media containing Rg1 at all three
concentrations (100, 50, 25 μM). Cell viability significantly
increased at 120, 150, 180, 210 and 240 min with Rg1
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treatment (Fig. 1a). Moreover, a dose-dependent effect was
also observed between 120 and 240 min (Fig. 1a). Conse-
quently, the higher, more effective dose of ginsenoside Rg1
(100 μM) was chosen for all subsequent experiments.
Annexin V-FITC flow cytometric analysis showed that
the population of Annexin V positive/PI negative cells
increased in a time-dependent manner. Rg1 treatment
decreased apoptosis by 5 to 15 % between 60 and 240 min
when compared to the corresponding time point of star-
vation model group (P < 0.05 or P < 0.01, Fig. 1b). Simi-
larly, TUNEL assay results showed that Rg1 treatment
reduced the starvation-induced increase of TUNEL-
positive cells at all time points (Fig. 1c, d).
A time-dependent increase in active caspase 3 levels
was observed between 0 and 120 min followed by a time-
dependent decline in both the model and Rg1 groups. In
both cases, peak levels were observed at 120 min after in-
duction of starvation. Rg1 treatment significantly de-
creased the levels of active caspase 3 by 39, 40, 37, 37, 44
and 59 % at 90, 120, 150, 180, 210 and 240min after induc-
tion of starvation respectively when compared to the
model group (Fig. 1e).
Fig. 1 The protective effects of ginsenoside Rg1 on starvation-induced apoptosis in H9c2 cells. a Effects of ginsenoside Rg1 doses on the cell
viability of H9c2 under starvation at 0, 30, 60, 90, 120, 150, 180, 210 and 240 min. H9c2 cells were incubated with ginsenoside Rg1 at either 25
(G-Rg1-L), 50 (G-Rg1-M) and 100 μM (G-Rg1-H) for 12 h. The cells were then cultured with or without ginsenoside Rg1 in serum and glucose-free
DMEM over 240 min. The time-course of cell viability was determined by MTT assay. Values are expressed as the mean ± SD, n = 3. #p < 0.05,
##p < 0.01, starvation model group (M) versus control group (0 min); *p < 0.05, **p < 0.01, ginsenoside Rg1 treatment groups (G-Rg1-L, G-Rg1-M,
G-Rg1-H) compared with the corresponding time point of starvation model (M). b, c Effects of ginsenoside Rg 1 on starvation-induced apoptosis in
H9c2 cells using TUNEL and Hoechst staining. d Effects ofginsenoside Rg1 on starvation-induced apoptosis in H9c2 cells using flow cytometric analysis
(Additional file 1: Figure S2). e Effects of ginsenoside Rg1 on expression of caspase 3 in H9c2 cells using Western blot analysis. Densitometric analysis
was used to quantify the levels of active caspase 3 in H9c2 cells with and without ginsenoside Rg1 treatment. Data is shown as mean ± SD, n = 3. *p <
0.05, **p < 0.01, starvation model group (30–240 min) versus the corresponding time point of starvation model group
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Rg1 promotes starvation-induced autophagy while inhi-
biting apoptosis in H9c2 cells
In the starvation model group, green fluorescence inten-
sity persistently increased over 90 min accompanied by
contraction of the cells. Four hours (240 min) after the
induction of starvation, the cells contracted to a spher-
ical shape, their movement stopped and the fluorescence
was quenched. In the Rg1 treatment group, however,
green fluorescence intensity began to increase at starva-
tion 60 min,then fluorescence was stable until quenched
after starvation 840 min and the normal cell morphology
was maintained over 420min after starvation (Fig. 2a),
suggesting that autophagic vacuolization may have oc-
curred and cell death was delayed in response to ginse-
noside Rg1 treatment.
As inefficient autophagic vesicle turnover (autophago-
some-lysosome fusion and/or down-stream cargo degrad-
ation) can lead to autophagic vesicle accumulation [33], we
proposed that Rg1 might induce autophagic vacuolization
by impairing autophagic vesicle turnover. Therefore, pro-
tein levels of LC3 and p62 in H9C2 cells were assessed
under starvation conditions at different time point follow-
ing induction of starvation. Western blot analysis revealed
that the LC3-II/LC3-I ratio was progressively up-regulated
during starvation, achieving statistical significance at 90
min and peaking at 150 min, before starting to decline
(Fig. 2b), while p62 protein levels were progressively re-
duced under starvation (Fig. 2c). When compared with the
corresponding time point of starvation model group, ginse-
noside Rg1 treatment significantly increased the LC3-II/
LC3-I ratio by 42, 37, 25 % at 30, 60 and 90 min respect-
ively (P < 0.05,or P < 0.01) and decreased p62 protein levels
at 30, 60, 90 and 120 min (P < 0.05). These results suggest
that Rg1 promotes autophagic activity in parallel with the
inhibition of apoptosis in H9c2 cells.
As illustrated in Fig. 2d, the expression of LC3-II was
significantly elevated in the presence of both chloroqui-
ne(CQ) and Rg1 when compared to the model, CQ and
Fig. 2 Ginsenoside Rg1 induces autophagy in H9c2 cells under starvation conditions. a Representative live cell images of GFP in H9c2 cells
transfected with GFP-LC3 for 48 h in the presence or absence of ginsenoside Rg1 under starvation. b, c Western blot analysis of endogenous LC3
and p62 in H9c2 cells after ginsenoside Rg1 treatment. Densitometric analysis was used to quantify the levels of LC3-II and p62 in H9c2 cells with
and without ginsenoside Rg1 treatment. Values are expressed as the mean ± SD, n = 3, #p < 0.05, ##p < 0.01, starvation model group (30–240 min)
versus starvation 0 min model group or *p < 0.05, ginsenoside Rg1 treatment group versus the corresponding time point of starvation. Trend
changes of LC3-II and p62 in H9c2 cells with and without ginsenoside Rg1 treatment. d Effects of ginsenoside Rg1 on LC3 levels in H9c2 cells in
the presence or absence of 5 μM CQ at 90 min after starvation by Western blot analysis. *p < 0.05, H9c2 cells in the presence of CQ and ginsenoside
Rg1 group (CQ + G-Rg1) versus ginsenoside Rg1-only group (G-Rg1)
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ginsenoside Rg1 treatment-only groups. This suggests a
CQ-induced accumulation of autophagic vesicles induced
by Rg1 treatment in H9c2 cells under starvation. This result
provides further evidence to support the concept that Rg1
promotes autophagy, without however significantly impair-
ing autophagic vesicle turnover. (The effect of CQ on dif-
feret time pionts showed in Additional file 2: Figure S3).
Rg1 mediates BECN1-Bcl- 2 interactions in H9c2
Caspase 3 levels (Fig. 3a) increased in the presence of
the inhibitor 3-MA and decreased in the presence of
Rap at the same time point. 3-MA and Rap could inhibit
or increase the expression of LC3-II of the model cell
(Fig. 3b). The combined data suggested that promoting
autophagy could suppress apoptosis and may be one of
the mechanisms underlying the protective effect of Rg1
on starving H9c2 cells. This result also highlights a po-
tential therapeutic target for reducing starvation-induced
apoptosis via promoting autophagy.
Beclin1 expression was upregulated between 30 and 150
min after commencement of starvation and then began to
decline to a statistically insignificant level (Fig. 4a). Mean-
while, no significant changes in Bcl-2 expression were
noted in response to starvation. Treatment with Rg1 mark-
edly increased levels of Beclin-1 and Bcl-2 at most time
points. When compared to the corresponding time of star-
vation model group, Rg1 treatment significantly increased
Beclin-1 protein levels by 24 to 88 % between 90 and 240
min (Fig. 4a) and Bcl-2 protein levels by 87 to 147 % be-
tween 90 and 210 min (Fig. 4b).
The immunoprecipitation and Western blot analyses
showed that BECN1 levels immunoprecipitating with
Bcl-2 steadily increased in a time-dependent manner
during starvation while free Bcl-2 levels decreased
gradually. Conversely, Rg1 treatment upregulated Bcl-2
while weakening the BECN1-Bcl-2 interaction in a time-
dependent manner (Fig. 5a). One hundred micrometer
Rg1 is the optimal dosage for protecting H9C2 cells
from starvation. It upregulated the ratio of Bcl-2 and
BECN1-Bcl-2 by 35 % (Fig. 5b).
In the starvation model group, YFP intensity started to
increase at 240 min after starvation then peaked at 420
min and commenced a gradual decline, reaching a plateau
at 480 min after starvation (Fig. 6a). Treatment with low
does of Rg1 (25μM), the YFP intensity markedly decreased
from 280 to 540 min when compared to the correspond-
ing time point of model group (Fig. 6b). Respectively, after
middle (50μM) and high (100μM) does of Rg1 treatment,
YFP intensity began to decrease at starvation 260 and 270
min (Fig. 6c, d). These results suggest that Rg1 produced
similar dose-dependent changes in YFP intensity and the
interaction between BECN1 and Bcl-2 may have been
weakened by ginsenoside Rg1.
Discussion
Previous studies have revealed multiple pharmacological
effects of ginsenoside Rg1. The present study reports for
the first time the dynamic regulatory effects of Rg1 on au-
tophagy and the interactions between autophagy and
apoptosis in H9c2 cells under starvation. These data pro-
vide evidence that Rg1 can partially inhibit the process of
apoptosis by enhancing autophagy under continuous star-
vation conditions.
Autophagy is an evolutionarily conserved pathway that
involves the sequestration and delivery of cytoplasmic ma-
terials to the lysosomes, where proteins are degraded and
recycled [36]. It is involved in organelle turnover and bio-
energetic management during starvation. In recent years,
Fig. 3 Effects of 3-MA Rap on LC3 and active caspase 3 in H9c2 cells. H9c2 cells were treated with 3-MA for 24 h or Rap for 12 h under normal
conditions and for 150 min under starvation. Expression of LC3 and active caspase 3 was determined by Western blot. Values are expressed as
the mean ± SD, n = 3. # p < 0.05 model group versus normal group; *p < 0.05, ginsenoside Rg1 treatment group verse starvation model group
(The effect of 3-MA and Rap on different time points showed in Additional file 2: Figures S4 and S5)
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Fig. 4 (See legend on next page.)
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the regulation and contribution of the autophagic process
to cell metabolism has been characterized in great detail.
As a process of consuming cellular components to gener-
ate energy, autophagy engages in a complex interconnec-
tion with apoptosis according to the nature of the
stimulus and cell type. It either suppresses apoptosis by
eliminating damaged organelles under cellular stress or
sensitizes cells to apoptosis, acting as an energy source.
There remains considerable debate as to the relationship
between autophagy and apoptosis. The dynamic processes
of autophagy and apoptosis have prompted the need to
understand how autophagy and apoptosis interact at dif-
ferent stages and in response to various conditions.
In the starvation model in H9c2 cells described here,
marker proteins of autophagy were initially evaluated.
The conversion of LC3-I (18 kDa) to LC3-II (16 kDa) is
a strong biochemical marker for the induction of au-
tophagy [37, 38]. The levels of LC3-II at different time
points under starvation condition were thus measured.
The LC3-II/LC3-I ratio was significantly increased at 90,
120, 150, 180 and 210 min after starvation when com-
pared to the control (Fig. 2b). This result is consistent
with that of Han et al. [37] who reported that the accu-
mulation of LC3-II in primary cardiomyocytes increased
at 1, 2, 3 and 6 h under starvation conditions. The exist-
ence of an induced autophagic flux was also evaluated
through the analysis of p62 levels, also called sequesto-
some 1 (SQSTM1). SQSTM1 is an ubiquitin-binding
scaffold protein that is localized to the autophagosome
via LC3-interaction and is specifically degraded by the
autophagy-lysosome system [39]. p62 levels are thus in-
versely related to autophagic activity. The results of the
present study showed that p62 levels were significantly
decreased in response to starvation (Fig. 2c).
Apoptosis is the principal mechanism by which cells
are physiologically eliminated in metazoan organisms
[30]. In the present study, the protein expression levels
of caspase 3, an indicator of apoptotic activity, were
measured. These results revealed that apoptosis and au-
tophagy occur simultaneously in H9c2 cardiomyocytes
under starvation conditions, but the dynamics of each
process differ. For example, when the starvation-induced
increases in LC3 expression reached their maximum, the
caspase 3 levels began to decline (Fig. 1d, e). Significant
changes in caspase 3 activity in cells incubated with 3-
MA or Rap were observed. In previous studies [12],
2mM 3-MA was shown to effectively block autophagic
activity, while 50 nM Rap effectively promoted autopha-
gic activity in cardiomyocytes. The results of the present
study showed that 3-MA enhanced starvation-induced
caspase 3 activation, whereas Rap restrained its eleva-
tion, thus suggesting that autophagy promotion played a
protective role in H9c2 cardiomyocytes under starvation
conditions (Fig. 3).
Rg1 has been demonstrated to have anti-ischemic,
anti-hypoxic and pro-autophagic properties [13]. In this
study, the effect of Rg1 on autophagy in H9c2 cardio-
myocytes was first investigated through determining the
fluorescence intensity of the fusion protein GFP-LC3,
which primarily represents the abundance of autophago-
somes [40]. To date, few studies have reported the use
of a real-time monitoring method for collection of the
fluorescent signal. In fact, the real-time monitoring of
green fluorescence in a single cell could provide vital in-
formation on the complete picture of GFP-LC3 changes
in response to starvation over time. In the present study,
Rg1 treatment not only increased fluorescence intensity
but also delayed the time for fluorescence quenching by
several hours. The existence of an induced autophagic
flux by Rg1 was also evaluated through the analysis of
LC3-II and p62 protein levels. Similarly, the results
showed that Rg1 brought forward the high peak time of
LC3-II/LC3-I and low peak time of p62, suggesting that
Rg1 treatment promotes starvation-induced autophagic
activities (Fig. 4). In addition, the effects of ginsenoside
Rg1 on apoptosis were also evaluated over multiple time
points. As measured by flow cytometry, Western blot and
TUNEL assay, Rg1 effectively inhibited starvation-induced
apoptosis in H9c2 cardiomyocytes at multiple time points.
To determine the mechanism underlying the regula-
tory effects of Rg1 on the relationship of autophagy and
apoptosis in starving H9c2 cells, the interaction of Bcl2
and BECN1 was investigated as an important link be-
tween apoptotic and autophagic activities. The BECN1
protein binds to Bcl2 through its BH3 domain. Under
normal circumstances, the BH3-only domain of BECN1
may competitively disrupt the bringing of pro-apoptotic
proteins to Bcl-2 or Bcl-XL, thus preventing the induc-
tion of apoptosis [41]. Under stress conditions, Beclin 1,
which is normally sequestered by Bcl-2, is released to in-
duce autophagy. The results of the present study showed
that Rg1 treatment upregulated the levels of Beclin 1 and
Bcl-2 protein compared with the starvation model group
at a slightly different time point. Immunoprecipitation is a
(See figure on previous page.)
Fig. 4 Increased expression of Beclin 1 and Bcl-2 in response to ginsenoside Rg1 in H9c2 cells under starvation conditions. a, b Western blot analysis
of endogenous Beclin 1 and Bcl-2 in H9c2 cells after treatment with and without ginsenoside Rg1. Values are expressed as the mean ± SD, n = 3,
#p < 0.05, ##p < 0.01, starvation model group (M) verse control group (0 min) or *p < 0.05, **p < 0.01, tarvation 30-240min model group verse
starvation 0min model group or *p < 0.05, **p < 0.01, ginsenos ide Rg1 treatment group (G-Rg1) verse the corresponding time point of
starvation model group
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classic method for studies of protein interactions. In the
present study, Rg1 promoted the dissociation of BECN1
and Bcl-2, increasing free BECN1 and Bcl-2 in the cyto-
plasm and consequently triggering the autophagic process
in a dose- and time-dependent manner. FRET is a physical
phenomenon by which energy from a donor fluorophore
in an excited state is non-radiatively transferred to a
neighboring acceptor fluorophore through dipole-dipole
Fig. 5 Effects of ginsenoside Rg1 on the interaction of Beclin 1 and Bcl-2 in H9c2 cells by immunoprecipitation. a, b Immunoprecipitation of Beclin 1
and Bcl-2 with or without ginsenoside Rg1 treatment demonstrated time-dependent changes (a) and the effect of 100 μM Rg1(b). Cell lysate was
extracted for immunoprecipitation with anti-Bcl-2 followed by probing with anti-Beclin1. Values are expressed as the mean ± SD, n = 3. #p < 0.05,
starvation 30-240min model group verse starvation 0min model group or *p < 0.05, ginsenoside Rg1 treatment group verse the corresponding
time point of starvation model group
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interactions. The strong dependence of FRET on distance
enables the use of FRET to measure molecular interactions
at a distance of 1–10 nm. The development of GFP and
variants such as yellow fluorescent protein (YFP, 516Ex/
527Em) and cyan fluorescent protein (CFP, 436Ex/476Em)
enables CFP/YFP to be used as a FRET pair. One of the
most important findings of this study is that, by using the
FRET assay, direct efficiency is provided that ginsenoside
Rg1 treatment weakened the interaction between Bcl-2 and
Beclin1 in the starving H9c2 cardiomyocytes (Fig. 6).
Fig. 6 Effects of ginsenoside Rg1 on the interaction of Beclin 1 and Bcl-2 in H9c2 cells by FRET. a Effect of ginsenoside Rg1 at low (b, 25 μM),
medium (c, 50 μM) and high (d, 100 μM) doses on FRET from CFP-Beclin 1 to YFP-Bcl-2 in live H9c2 cells. Compared to the corresponding time
point of starvation model group, ginsenoside Rg1 treatment decreased FRET in live cells from 240 to 470 min in a dose-dependent manner.
Values are expressed as the mean ± SD, n = 3. ##p < 0.01, starvation 240–480 min model group (M) verse starvation 0 min model group or
*p < 0.05, **p < 0.01, ginsenoside Rg1 treatment group verse the corresponding time point of starvation model group
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Conclusions
Our results support the theory that starvation contributes
to the induction of autophagic activities in H9c2 cardio-
myocytes. Ginsenoside Rg1 could prevent cellular apop-
tosis via initiating an autophagic survival response, during
which time Rg1 could promote the expression of Beclin1
and Bcl-2 and weaken the interaction between Beclin1
and Bcl-2. This study has demonstrated for the first time a
novel role for ginsenoside Rg1 in inducing a beneficial
autophagic activity in cardiomyocytes under starvation.
Additional files
Additional file 1: Figure S1. Cell viability of H9c2 cells. Cell viability
significantly decreased in a time-dependent manner between 30 and 240
min when compared with the control (0 min). Values are expressed as
the mean ± SD, n = 3. **p < 0.01, starvation model group verse control
group. Figure S2. Effects of ginsenoside Rg1 on starvation-induced
apoptosis in H9c2 cells using flow cytometric analysis. (PDF 346 kb)
Additional file 2: Figure S3. The effect of CQ on different time
points. The LC3 level significantly increased at 90 min (*p < 0.01). Figure
S4. The effect of 3-MA on different time points. The LC3 level significantly
decreased at 12 h (*p < 0.05) and 24 h (*p < 0.05). Figure S5. The effect
of Rap on different time points. The LC3 level significantly increased at 12
h (**p < 0.01) and 24 h (*p < 0.05). (XLSX 33 kb)
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